Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL672872 | 0.83 | CYP2C19 (0.39) | CYP2C19 | |
| SCHEMBL134919 | 0.81 | TSHR (0.39) | — | |
| Ethylene Glycol SCHEMBL3620190 | 0.78 | CYP2C19 (0.30) | CYP2C19 | |
| Ethylene Glycol SCHEMBL28396571 | 0.78 | TSHR (0.37) | — | |
| SCHEMBL4967622 | 0.78 | TSHR (0.37) | — | |
| SCHEMBL10308656 | 0.75 | — | — | |
| SCHEMBL11422255 | 0.74 | CA1 (0.34) | — | |
| Ethylene Glycol SCHEMBL1966294 | 0.73 | CYP2C19 (0.32) | CYP2C19 | |
| SCHEMBL13909030 | 0.72 | — | — | |
| SCHEMBL673868 | 0.72 | CYP2C19 (0.35) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2334691-A1 | PHOSPHORUS-CONTAINING COMPOUNDS AND POLYMERIC COMPOSITIONS COMPRISING SAME | Dow Global Technologies LLC (US) | 2011-06-22 | — | — | EP | disclosed |
| US-20110136993-A1 | PHOSPHORUS-CONTAINING COMPOUNDS AND POLYMERIC COMPOSITIONS COMPRISING SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-06-09 | — | — | US | disclosed |
| WO-2010025165-A1 | PHOSPHORUS-CONTAINING COMPOUNDS AND POLYMERIC COMPOSITIONS COMPRISING SAME | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-03-04 | — | — | WO | disclosed |
| JP-2003229173-A | FLAME-RETARDANT ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL & TECHNOLOGY | 2003-08-15 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136993-A1 | PHOSPHORUS-CONTAINING COMPOUNDS AND POLYMERIC COMPOSITIONS COMPRISING SAME | PHOSPHO1, FOLR2, FOLR1 | CYP2C19 2997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.